SCHEMBL5222789

SCHEMBL5222789

O=S(=O)(c1ccccc1)N1CCN(c2nc(-c3ccccc3)c3cc(Cl)ccc3n2)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.68
ALDH1A1 P00352 5/20 0.68
NPSR1 Q6W5P4 4/20 0.68
USP2 O75604 4/20 0.68
CASP1 P29466 2/20 0.68
CASP7 P55210 2/20 0.68
LMNA P02545 4/20 0.65
KMT2A Q03164 3/20 0.65
S1PR2 O95136 1/20 0.65
HIF1A Q16665 1/20 0.65
SMN1; SMN2 Q16637 5/20 0.62
MAPT P10636 4/20 0.62
TSHR P16473 2/20 0.62
TP53 P04637 1/20 0.62
HTT P42858 3/20 0.54
GAA P10253 2/20 0.54
PKM P14618 2/20 0.54
GBA1 P04062 5/20 0.53
MAPK1 P28482 4/20 0.53
TDP1 Q9NUW8 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14586373 0.81 KDM4E (1.00) KDM4EALDH1A1NPSR1USP2CASP1
SCHEMBL5786483 0.79 KDM4E (1.00) KDM4EALDH1A1NPSR1USP2CASP1
SCHEMBL5220419 0.75 KDM4E (0.64) KDM4EALDH1A1NPSR1USP2CASP1
SCHEMBL5222798 0.73 KDM4E (0.61) KDM4EALDH1A1NPSR1USP2CASP1
SCHEMBL5786677 0.71 KDM4E (0.84) KDM4EALDH1A1NPSR1USP2CASP1
SCHEMBL15775046 0.70 ALDH1A1 (1.00) KDM4EALDH1A1NPSR1USP2CASP1
SCHEMBL20887055 0.70 ALDH1A1 (0.64) KDM4EALDH1A1NPSR1USP2LMNA
SCHEMBL31217463 0.70 HTT (1.00) KDM4EALDH1A1NPSR1USP2LMNA
SCHEMBL4310769 0.70 POLB (0.88) KDM4EALDH1A1NPSR1USP2KMT2A
SCHEMBL17368690 0.70 ALDH1A1 (0.88) KDM4EALDH1A1NPSR1USP2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009817-A1 Substituted heteroaryls INSTITUTES FOR PHARMACEUTICAL DISCOVERY, L.L.C. 2005-01-13 US claimed
EP-1618094-B1 SUBSTITUTED HETEROARYLS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INST FOR PHARM DISCOVERY INC (US) 2007-09-05 EP disclosed
EP-1618094-B1 SUBSTITUTED HETEROARYLS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INST FOR PHARM DISCOVERY INC (US) 2007-09-05 EP disclosed
US-20050009817-A1 Substituted heteroaryls INSTITUTES FOR PHARMACEUTICAL DISCOVERY, L.L.C. 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009817-A1 Substituted heteroaryls PTPRS, PTPRO, PTPRR KDM4E 1400/4885ALDH1A1 477/4885NPSR1 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.